Dr. Amusa Sarafadeen Adebayo is an Associate Professor of Pharmaceutical Sciences at Howard University. He completed his B. Pharm. and MSc. studies in Pharmaceutics in the Faculty of Pharmacy in 1989 and 1999, respectively; MBA studies in the Faculty of Administration of Obafemi Awolowo University (OAU) in 1999; MS studies in Health Informatics at UIC in 2020; and PhD studies in Pharmaceutics at the University of Ibadan in 2001. He was awarded the Biggest Heart and Faculty Merit awards at RUCOP in 2014. His research interests include active targeted delivery of niosomal combination drugs to H. pylori cells and sequential passive-active targeted delivery of niosomal combination drugs for colorectal cancer.
Dr. Amusa Sarafadeen Adebayo is an Associate Professor of Pharmaceutical Sciences at Howard University. He completed his B. Pharm. and MSc. studies in Pharmaceutics in the Faculty of Pharmacy in 1989 and 1999, respectively; MBA studies in the Faculty of Administration of Obafemi Awolowo University (OAU) in 1999; MS studies in Health Informatics at UIC in 2020; and PhD studies in Pharmaceutics at the University of Ibadan in 2001. He was awarded the Biggest Heart and Faculty Merit awards at RUCOP in 2014. His research interests include active targeted delivery of niosomal combination drugs to H. pylori cells and sequential passive-active targeted delivery of niosomal combination drugs for colorectal cancer.